Neonatal ventral hippocampus (nVH) lesion in rats is a widely used animal model of
schizophrenia due to the predominantly post-pubertal emergence of many
schizophrenia-like behaviours. Our previous studies have shown increased
ligand binding of alpha1
adrenergic receptors (AR) in the frontal cortex of post-pubertal, but not pre-pubertal, nVH-lesioned rats, compared to
sham-lesioned control rats. Moreover, pretreatment with the alpha1
adrenergic receptor antagonist
prazosin reversed
amphetamine-induced hyperlocomotion in controls, but failed to do so in lesioned animals. This led to our hypothesis that nVH lesions may lead to post-pubertal hyperactivity of alpha1
adrenergic receptors. In order to test the functional relevance of alpha1
adrenergic hyperactivity to
schizophrenia-like behaviours of nVH-lesioned animals, we conducted prepulse inhibition (PPI) studies in post-pubertal (postnatal days 56-120)
sham and lesioned animals in response to systemic
injections of alpha1
adrenergic receptor antagonist and agonist,
prazosin and
cirazoline, respectively. Our results show that PPI deficits in nVH-lesioned animals were reversed with
prazosin treatment, without a significant effect on PPI in
sham animals. Further, at various doses,
cirazoline had a significantly greater PPI disruptive effect in nVH-lesioned animals than in
sham animals. Together, these results suggest that nVH-lesioned animals show a hyperactive alpha1
adrenergic receptor system that may mediate sensorimotor gating abnormalities reported in these animals.